dbo:abstract
|
- SB-200646 is a 5-HT2 receptor antagonist with anxiolytic properties in rats. It was the first 5-HT2 antagonist discovered to have selectivity of 5-HT2C/2B over 5-HT2A. (en)
|
dbo:casNumber
| |
dbo:chEBI
| |
dbo:chEMBL
| |
dbo:kegg
| |
dbo:pubchem
| |
dbo:thumbnail
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 2162 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:atcPrefix
| |
dbp:c
| |
dbp:casNumber
| |
dbp:chebi
| |
dbp:chembl
| |
dbp:chemspiderid
| |
dbp:h
| |
dbp:iupacName
| |
dbp:kegg
| |
dbp:legalUn
| |
dbp:n
| |
dbp:o
| |
dbp:pubchem
| |
dbp:smiles
|
- Cn1ccc2c1cccNCNc3cccnc3 (en)
|
dbp:stdinchi
| |
dbp:stdinchikey
|
- OJZZJTLBYXHUSJ-UHFFFAOYSA-N (en)
|
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
gold:hypernym
| |
rdf:type
| |
rdfs:comment
|
- SB-200646 is a 5-HT2 receptor antagonist with anxiolytic properties in rats. It was the first 5-HT2 antagonist discovered to have selectivity of 5-HT2C/2B over 5-HT2A. (en)
|
rdfs:label
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:depiction
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageRedirects
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |